Global collaboration is the world’s best shot at ending the pandemic – here’s what Big Pharma can do

In a viewpoint for the Telegraph, Dag-Inge Ulstein, Minister of International Development for the Norwegian Government, and John-Arne Røttingen, Chief Executive for the Research Council of Norway (RCN) point to four ways pharma can improve access to medicine.

In this piece, the authors use findings from the 2021 Access to Medicine Index to identify four areas where pharmaceutical companies can take urgent action to ensure equal access to COVID-19 vaccines and treatments in low- and middle-income countries (LMICs).:

File for registration rapidly, widely and on the basis of the most rigorous standards
Price products equitably
Expand production and supply capacity
Disclose more information about efforts and progress against these principals

Read the full article here.

Global collaboration is the world’s best shot at ending the pandemic – here’s what Big Pharma can do

Can Novartis really make its medicines available to everyone?

Get in touch

Suzanne Wolf